Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target

S Safe, P Imanirad, S Sreevalsan, V Nair… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Specificity protein (Sp) transcription factors (TFs) are members of the
Sp/Kruppel-like factor family, and Sp proteins play an important role in embryonic and early …

Tailor‐made nanomaterials for diagnosis and therapy of pancreatic ductal adenocarcinoma

X Hu, F Xia, J Lee, F Li, X Lu, X Zhuo, G Nie… - Advanced …, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide due to
its aggressiveness and the challenge to early diagnosis and treatment. In recent decades …

Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production

MS Wason, J Colon, S Das, S Seal, J Turkson… - … , Biology and Medicine, 2013 - Elsevier
Side effect of radiation therapy (RT) remains the most challenging issue for pancreatic
cancer treatment. In this report we determined whether and how cerium oxide nanoparticles …

[HTML][HTML] Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of …

H Jin, A Kanthasamy, DS Harischandra… - Journal of Biological …, 2014 - ASBMB
The oxidative stress-sensitive protein kinase Cδ (PKCδ) has been implicated in
dopaminergic neuronal cell death. However, little is known about the epigenetic …

Survivin as a biological biomarker for diagnosis and therapy

Y Li, W Lu, J Yang, M Edwards… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Survivin (SVN) is a member of the inhibitor of apoptosis (IAP) protein family that
promotes cellular proliferation and inhibits apoptosis. Overexpression of SVN is associated …

[HTML][HTML] Cerium oxide nanoparticles sensitize pancreatic cancer to radiation therapy through oxidative activation of the JNK apoptotic pathway

MS Wason, H Lu, L Yu, SK Lahiri, D Mukherjee… - Cancers, 2018 - mdpi.com
Side effects of radiation therapy (RT) remain the most challenging issue for pancreatic
cancer treatment. Cerium oxide nanoparticles (CONPs) are currently being tested in pre …

Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity

Z Jia, Y Gao, L Wang, Q Li, J Zhang, X Le, D Wei… - Cancer research, 2010 - AACR
Mithramycin (MIT) and tolfenamic acid (TA) inhibit the activity of the transcription factor Sp1.
In the present study, we investigated whether pancreatic cancer treatment with a …

[HTML][HTML] Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen …

UT Sankpal, GP Nagaraju, SR Gottipolu, M Hurtado… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Curcumin (Cur) has been extensively studied in several types of malignancies including
colorectal cancer (CRC); however its clinical application is greatly affected by low …

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells

Y Qian, B Hong, L Shen, Z Wu, H Yao, L Zhang - Cell and tissue research, 2013 - Springer
B7-H4 is expressed in a variety of tumor cells and functions as a negative regulator of T
cells. However, clarification is needed as to whether B7-H4 mediates tumorigenesis through …

Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice

GM Subaiea, LI Adwan, AH Ahmed, KE Stevens… - Neurobiology of …, 2013 - Elsevier
Tolfenamic acid lowers the levels of the amyloid precursor protein (APP) and amyloid beta
(Aβ) when administered to C57BL/6 mice by lowering their transcriptional regulator …